Periodic Reporting for period 1 - Nano4Rare (Preclinical development of a nanomedicine candidate for Fabry rare disease treatment to enter clinical phase)

Despite the development of new orphan medicines in recent years, there are still limited treatment options available for rare diseases. Nano4Rare team has developed a patent protected nanoencapsulation KET for the development of cost-effective therapies for rare diseases...